Sedative drug tested as shield for transplanted livers
NCT ID NCT05031026
Summary
This study is testing if a drug called dexmedetomidine, given during surgery, can protect a newly transplanted liver from damage. The goal is to see if this protection helps the new liver work better right away and reduces other complications like kidney or lung problems after the operation. The trial involves 60 adults receiving a liver from a living donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assiut University
Asyut, 088, Egypt
Conditions
Explore the condition pages connected to this study.